Importantly, primary breast cancers that over-express HER3 are associated with a significantly higher rate of isolated brain metastases [22], and induction of HER3 is associated with development of brain metastases from both breast and lung cancers [23, 24]. Here, ERBB3 is linked to lung cancer.